Morvan, Valérie Le
Richard, Élodie
Cadars, Maud
Fessart, Delphine
Broca-Brisson, Léa
Auzanneau, Céline
Pasquies, Alban
Modesto, Anouchka
Lusque, Amélie
Mathoulin-Pélissier, Simone
Lansiaux, Amélie
Robert, Jacques
Funding for this research was provided by:
Ligue Nationale contre le Cancer, comité des Landes
Article History
Received: 19 October 2019
Accepted: 22 May 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: CAL27 and CAL33 HNSCC cell lines were kindly provided by Dr J.L. Fischel (Centre Antoine Lacassagne, Nice, France, where they were initially obtained). They were authenticated by Azur Génétique (Nice, France) as identical to the corresponding DSMZ cell lines (report reference AGLC-14-00225). The study was approved by the local ethical committee (Comité de Protection des Personnes de Bordeaux), and written informed consent was provided by all the participants after a full explanation of the study was given to them. This study was performed in accordance with the Declaration of Helsinki and was registered under ref. NCT-01827956.
: Not applicable.
: Raw results of the RNA-seq are available on the Annotare platform (ArrayExpress accession #E-MTAB-8512).
: The authors declare no competing interests.
: This work was made possible through grants from the Ligue Nationale contre le Cancer (comité des Landes) and from GEFLUC-Aquitaine.